Private sector's role in UK healthcare
This article was originally published in Clinica
The private sector holds the key to UK healthcare reform, argues Dr Tim Evans, a policy expert and spokesman for independent healthcare providers. In the latest of a promotional series sponsored by Pfizer Europe, Dr Evans suggests that non- governmental expenditure may be the "only viable way forward" in the NHS policy debate.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.